MedWatch

Zealand Pharma shares are the year’s best in life science – value has risen by 95 percent.

Shares in Zealand Pharma have increased most in value compared to shares in other life science companies so far this year. Their value has shot up by 95% since the start of 2019. “We could be worth more,” says the CEO.

Zealand Pharma has had a Herculean 2019 on the stock exchange so far. Photo: Zealand Pharma/ PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles